Search

everythinglearnresearchcommunity

for

Search:↓

Chemical hair straightening can damage hair and health, needing safer alternatives and stricter regulations.

Alopecia patients had similar element levels to normal people, except for differences in copper and low selenium.

Shampoo pH can affect hair health, with alkaline shampoos potentially causing damage and acidic shampoos reducing frizz.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

Certain medications and maintaining adequate iron levels can help manage women's hair loss.

Most Indian people with hair loss in the study lacked nutrients, especially iron.

Adding zinc to pyrithione zinc improves its effectiveness against scalp conditions like dandruff.

The main causes of diffuse hair loss in women are telogen effluvium and androgenetic alopecia, often related to stress and iron deficiency.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Genetics and nutritional deficiencies are key factors in premature graying of hair.

The HairCheck® device is effective for measuring hair loss and growth in people with alopecia.

Zinc pyrithione needs targeted delivery to the scalp for effective dandruff treatment.

Dermoscopy helps quickly identify hair breakage in people of African descent.

New treatments like plant extracts, nanocarriers, and 3D bioprinting show promise for hair loss, but more research is needed.

Younger people may have a higher risk of hair loss due to poor nutrition and lifestyle.

Melitane 5% and hair supplements improved hair color in a 14-year-old with early graying.

Heavy metals might contribute to hair loss in Telogen Effluvium.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

The balance of thiol-disulfide in women with hair loss is affected but not damaged.

A patient with a scalp condition and benign skin tumor experienced hair loss and did not improve with treatment, choosing not to have surgery despite a small cancer risk.

The comprehensive treatment with biomimetic peptide lotion was effective for hair loss.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

Hair loss in a child was an early sign of Crohn's disease.

Women with hair loss often have deficiencies in iron, vitamins, minerals, and lower thyroid function, suggesting the need for nutritional and hormonal treatment.

Specific tests may help diagnose alopecia, but their treatment impact is unclear.

Herbal remedies may help with hair loss but need more research.